4.7 Article

High TCL1 levels are a marker of B-cell receptor pathway responsiveness and adverse outcome in chronic lymphocytic leukemia

相关参考文献

注意:仅列出部分参考文献,下载原文获取全部文献信息。
Review Hematology

New prognostic markers in chronic lymphocytic leukemia

Carol Moreno et al.

BLOOD REVIEWS (2008)

Article Multidisciplinary Sciences

TORC2 regulates germinal center repression of the TCL1 oncoprotein to promote B cell development and inhibit transformation

Ali I. Kuraishy et al.

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2007)

Article Multidisciplinary Sciences

B cell receptors in TCL1 transgenic mice resemble those of aggressive, treatment-resistant human chronic lymphocytic leukemia

Xiao-jie Yan et al.

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2006)

Article Medicine, General & Internal

ZAP-70 expression and prognosis in chronic lymphocytic leukaemia

JA Orchard et al.

LANCET (2004)

Article Medicine, General & Internal

ZAP-70 expression as a surrogate for immunoglobulin-variable-region mutations in chronic lymphocytic leukemia

M Crespo et al.

NEW ENGLAND JOURNAL OF MEDICINE (2003)

Article Multidisciplinary Sciences

Human chronic lymphocytic leukemia modeled in mouse by targeted TCL1 expression

R Bichi et al.

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2002)

Article Medicine, Research & Experimental

TCL1 oncogene expression in B cell subsets from lymphoid hyperplasia and distinct classes of B cell lymphoma

JW Said et al.

LABORATORY INVESTIGATION (2001)

Article Biochemistry & Molecular Biology

The protooncogene TCL1 is an Akt kinase coactivator

J Laine et al.

MOLECULAR CELL (2000)